ZielBio is a biotechnology company that identifies novel disease targets and develops therapeutic interventions to improve patient outcomes. The company offers Zielfind, a drug discovery platform that combines functional screening with large content data analytics to identify high value targets. It has a pipeline of therapies and targets, including ZB131, a cancer target identified through Zielfind.